For the first time, thanks to CRISPR scissors, the genome of reptiles has been edited. American researchers have managed to ...

Researchers have mapped the regulatory elements that control the FOXP3 gene, which is implicated in maintaining balance in ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

This biotech has already made impressive contributions to medicine, and it could make more. But does that make it a buy?

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Only one in every six million people have the Rh null blood type. Now researchers are trying to grow it in the laboratory in ...

A U.S. biological research institute has developed a new genetic modification technique that promises a wide range of organism mutations while being safer than the ...

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered ...